Hereditary ataxias

Mayo Clinic Proceedings

Volumn 75, Issue 5, 2000, Pages 475-490

  Evidente, Virgilio Gerald H ^a   Gwinn Hardy, Katrina A ^b   Caviness, John N ^c   Oilman, Sid ^a,b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; DNA; GENE PRODUCT; PHOSPHOGLYCERATE KINASE; POLYGLUTAMINE; TRINUCLEOTIDE;

ATAXIA TELANGIECTASIA; CEREBELLAR ATAXIA; COCKAYNE SYNDROME; FRIEDREICH ATAXIA; GENE MUTATION; GENETIC COUNSELING; GENOTYPE; HEARING IMPAIRMENT; HEREDITARY ATAXIA; HUMAN; HYPOGONADISM; MACHADO JOSEPH DISEASE; MARINESCO SJOGREN SYNDROME; NONHUMAN; PHENOTYPE; RETINITIS PIGMENTOSA; REVIEW; TRINUCLEOTIDE REPEAT; XERODERMA PIGMENTOSUM;

EID: 0034021172     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/75.5.475     Document Type: Review

References (177)

1. Campuzano V, Montermini L, Molto MD, et al. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science. 1996;271:1423-1427.
2. Bidichandani SI, Ashizawa T, Patel PI. The GAA triplet-repeat expansion in Friedreich ataxia interferes with transcription and may be associated with an unusual DNA structure. Am .1 Hum Genet. 1998:62:111-121.
3. Durr A, Cossee M, Agid Y, et al. Clinical and genetic abnormalities in patients with Friedreich's ataxia. N EnglJ Med. 1996;335: 1169-1175.
4. Geoffroy G, Barbeau A, Breton G, et al. Clinical description and roentgenologic evaluation of patients with Friedreich's ataxia. Can J Neural Sci. 1976;3:279-286.
5. Filla A, Cavalcanti F, De Michcle G, et al. Friedreich's ataxia after gene cloning: the sensitivity and specificity of clinical diagnosis [abstract]. Neurology. 1997;48(suppl 2):A178-A179.
6. Oilman S, Junck L, Markel DS, Koeppe RA, Kluin KJ. Cerebral glucose hypermetabolism in Friedreich's ataxia detected with positron emission tomography. Ann Neural. 1990;28:750-757.
7. Junck L, Oilman S, Gebarski SS. Koeppe RA, Kluin KJ, Markel DS. Structural and functional brain imaging in Friedreich's ataxia. Arch Neural. \994;51:349-355.
8. Epplen C, Epplen JT, Frank G, Miterski B, Santos EJ, Schols L. Differential stability of the (GAA)n tract in the Friedreich ataxia (STM7) gene. Hum Genet. 1997;99:834-836.
9. De Michèle G, Filla A, Cavalcanti F, et al. Late onset Friedreich's disease: clinical features and mapping of mutation to the FRDA locus. J Neural Neurosurg Psychiatry. 1994:57:977-979.
10. Harding AE. Early onset cerebellar ataxia with retained tendon reflexes: a clinical and genetic study of a disorder distinct from Friedreich's ataxia. ,J Neural Neurasur'g Psychiatry. 1981;44: 503-508.
11. Ragno M, De Michèle G, Cavalcanti F, et al. Broadened Friedreich's ataxia phenotype after gene cloning: minimal GAA expansion causes late-onset spastic ataxia. Neurology. 1997;49: 1617-1620.
12. Palau F, De Michèle G, Vilchez JJ, et al. Early-onset ataxia with cardiomyopathy and retained tendon reflexes maps to the Friedreich's ataxia locus on chromosome 9q. Ann Neural. 1995:37:359-362.
13. Barbeau A, Roy M, Sadibelouiz M, Wilensky MA. Récessive ataxia in Acadians and "Cajuns." Can J Neural Sci. 1984; ll(suppl):526-533.
14. Keats BJ, Ward LJ, Shaw J, Wickremasinghe A, Chamberlain S. "Acadian" and "classical" forms of Friedreich ataxia are most probably caused by mutations at the same locus. Am J Med Genet. 1989:33:266-268.
15. Montermini L, Richter A, Morgan K, et al. Phenotypic variability in Friedreich ataxia: role of the associated GAA triplet repeat expansion. Ann Neural. 1997;41:675-682.
16. Campuzano V, Montermini L, Lutz Y, et al. Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondria! membranes. Hum Mol Genet. 1997;6:1771 -1780.
17. Gibson TJ, Koonin EV, MuscoG, Pastore A, Bork P. Friedreich's ataxia protein: phylogenetic evidence for mitochondria! dysfunction. Trends Neurasci. 1996:19:465-468.
18. Babcock M, de Suva D, Oaks R, et al. Regulation of mitochondria! iron accumulation by Yfhlp, a putative homolog of frataxin. Science. 1997;276:1709-1712.
19. Priller J, Scherzer CR, Faber PW, MacDonald ME, Young AB. Frataxin gene of Friedreich's ataxia is targeted to mitochondria. Ann Neural. 1997;42:265-269.
20. Foury F, Cazzalini O. Deletion of the yeast homologue of the human gene associated with Friedreich's ataxia elicits iron accumulation in mitochondria. FEBS Lett. 1997:411:373377.
21. Eder K, Kish SJ, Kirchgessner M, Ross BM. Brain phospholipids and fatty acids in Friedreich's ataxia and spinocerebellar atrophy type-1. Mov Disord. 1998; 13:813-819.
22. Harding AE, Matthews S, Jones S, Ellis CJ, Booth IW, Muller DP. Spinocerebellar degeneration associated with a selective defect of vitamin E absorption. N Engl J Med. 1985;313:3235.
23. Ben Hamida C, Doerflinger N, Bêlai S, et al. Localization of Friedreich ataxia phenotype with selective vitamin E deficiency to chromosome 8q by homozygosity mapping. Nat Genet. 1993; 5:195-200.
24. Yokota T, Shiojiri T, Gotoda T, et al. Friedreich-like ataxia with retinitis pigmentosa caused by the His 101 Gin mutation of the alpha-tocopherol transfer protein gene. Ann Neural. 1997;41: 826-832.
25. Hentati F, Mrissa N, Zouari M, Belal S, Ben Hamida C, Ben Hamida M. Exclusion of genetic linkage between autosomal recessive hereditary ataxia with brisk knee and absent ankle reflexes and Friedreich's ataxia phenotypes loci [abstract]. Neurology. 1997;48(suppl 2):A178.
26. Higgins JJ, Morton DH, Patronas N, Nee LE. An autosomal recessive disorder with posterior column ataxia and retinitis pigmentosa. Neurology. 1997;49:1717-1720.
27. Nikali K, Koskinen T, Suomalainen A, Pihko H, Peltonen L. Infantile onset spinocerebellar ataxia represents an allelic disease distinct from other hereditary ataxias. Pediatr Res. 1994;36:607612.
28. Koskinen T, Valanne L, Ketonen LM, Pihko H. Infantile-onset spinocerebellar ataxia: MR and CT findings. AJNR Am J Neuroradiol. 1995; 16:1427-1433.
29. Nikali K, Suomalainen A, Terwilliger J, Koskinen T, Weissenbach J, Peltonen L. Random search for shared chromosomal regions in four affected individuals: the assignment of a new hereditary ataxia locus. Am J Hum Genet. 1995;56:10881095.
30. Chan SO, Peng D, Chiu FC. Heterogeneous expression of neurofilament proteins in forebrain and cerebellum during development: clinical implications for spinocerebellar ataxia. Brain Res. 1997;775:107-118.
31. Leber S. Progressive myoclonus epilepsy. In: Dodson WE. Pellock JM, eds. Pédiatrie Epilepsy: Diagnosis and Therapy. New York, NY: Demos; 1993:171-181.
32. Malafosse A, Lehesjoki AE, Genton P, et al. Identical genetic locus for Baltic and Mediterranean myoclonus. Lancet. 1992; 339:1080-1081.
33. Virtaneva K, D'Amato E, Miao J, et al. Unstable minisatellite expansion causing recessively inherited myoclonus epilepsy, EPM1. Nat Genet. 1997; 15:393-396.
34. Lalioti MD, Mirotsou M, Buresi C, et al. Identification of mutations in cystatin B, the gene responsible for the UnverrichtLundborg type of progressive myoclonus epilepsy (EPM1 ). Am J Hum Genet. 1997:60:342-351.
35. Pennacchio LA, Lehesjoki AE, Stone NE, et al. Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EOM1 ). Science. 1996;271:1731-1734.
36. Lafreniere RG, Rochefort DL, Chrétien N, et al. Unstable insertion in the 5' flanking region of the cystatin B gene is the most common mutation in progressive myoclonus epilepsy type 1, EPM 1. Nat Genet. 1997; 15:298-302.
37. Holmes G. A form of familial degeneration of the cerebellum. Brain. 1907:30:466-489.
38. Fok AC, Wong MC, Cheah JS. Syndrome of cerebellar ataxia and hypogonadotrophic hypogonadism: evidence for pituitary gonadotrophin deficiency. J Neural Neurosurg Psychiatry. 1989; 52:407-409.
39. Malandrini A, Villanova M, Piomboni P, et al. Ultrastructural sperm abnormalities and cerebellar atrophy: does a correlation exist? report of two cases without endocrine hypogonadism. J Suhmicrosc Cytol Pathol. 1993;25:371-375.
40. Tojo K, Ichinose M, Nakayama M, et al. A new family of Boucher-Neuhauser syndrome: coexistence of Holmes type cerebellar atrophy, hypogonadotropic hypogonadism and retinochoroidal degeneration: case reports and review of literature. EndocrJ. 1995;42:367-376.
41. Marinesco G, Draganesco S, Vasiliu D. Nouvelle maladie familiale caractérisée par une cataracte congénitale et un arrêt du développement somato-neuropsychique. Encéphale. 1931;26:97109.
42. Bromberg MB, Junck L, Gebarski SS, McLean MJ, Oilman S. The Marinesco-Sjogren syndrome examined by computed tomography, magnetic resonance, and 18F-2-fluoro-2-deoxy-Dglucose and positron emission tomography. Arch Neural. 1990; 47:1239-1242.
43. Todorov A. Le syndrome de Marinesco-Sjogren: première étude anatomo-clinique. J Genet Hum. 1965; 14:197-233.
44. Walker PD, Blitzer MG, Shapira E. Marinesco-Sjogren syndrome: evidence for a lysosomal storage disorder. Neurology. 1985;35:415-419.
45. Skre H, Berg K. Linkage studies on Marinesco-Sjogren syndrome and hypergonadotropic hypogonadism. Clin Genet. 1977; 11:57-66.
46. Horoupian DS, Zucker DK, Moshe S, Peterson HD. Behr syndrome: a clinicopathologic report. Neurology. 1979;29:323-327.
47. Landrigan PJ, Berenberg W, Bresnan M. Behr's syndrome: familial optic atrophy, spastic diplegia and ataxia. Dev Med Child Neurol. 1973;15:41-47.
48. Marzan KA, Barron TF. MR1 abnormalities in Behr syndrome. Pediatr Neurol. 1994; 10:247-248.
49. Begeer JH, Schölte FA, van Essen AJ. Two sisters with mental retardation, cataract, ataxia, progressive hearing loss, and polyneuropathy. J Med Genet. 1991 ;28:884-885.
50. Bitoun P, Bandini D, Rigaudiere F. A hereditary syndrome with retinopathy and ataxia or deafness in two consanguineous brothers. Ophthalmic Paediatr Genet. 1991;12:149-152.
51. Ragno M, Curatola L, Rossi R, Salvolini U. Clinical, multimodal electrophysiological study of a family with progressive cerebellar ataxia and late deafness and an autosomal recessive inheritance [in Italian]. Acta Neurol (Napoli). 1992; 14:431-439.
52. Matthews WB. Familial ataxia, deaf-mutism, and muscular wasting. J Neurol Neurosurg Psychiatry. 1950; 13:307-311.
53. Pratap-Chand R, Gururaj AK, Dilip-Kumar S. A syndrome of olivopontocerebellar atrophy and deafness with onset in infancy. Acta Neurol Scand. 1995;91:133-136.
54. Boder E, Sedgwick P. Ataxia telangiectasia: a review of 101 cases. Dev Med. 1963;8:110-118.
55. Gatti RA, Boder E, Vinters HV, Sparkes RS, Norman A, Lange K. Ataxia-telangiectasia: an interdisciplinary approach to pathogenesis. Medicine (Baltimore). 1991;70:99-117.
56. Woods CG, Taylor AM. Ataxia telangiectasia in the British Isles: the clinical and laboratory features of 70 affected individuals. QJ Med. 1992;82:169-179.
57. Waldmann TA, Mclntire KR. Serum-alpha-fetoprotein levels in patients with ataxia-telangiectasia. Lancet. 1972;2:1112-1115.
58. Jaspers NG, Gatti RA, Baan C, Linssen PC, Bootsma D. Genetic complementation analysis of ataxia telangiectasia and Nijmegen breakage syndrome: a survey of 50 patients. Cytogenet Cell Genet. 1988;49:259-263.
59. Ziv Y, Rotman G, Frydman M, et al. The ATC (ataxiatelangiectasia complementation group C) locus localizes to 1 Iq22-q23. Genomics. 1991;9:373-375.
60. Foroud T, Wei S, Ziv Y, et al. Localization of an ataxiatelangiectasia locus to a 3-cM interval on chromosome 1 Iq23: linkage analysis of 111 families by an international consortium. Am J Hum Genet. 1991 ;49:1263-1279.
61. Savitsky K, Bar-Shira A, Gilad S, et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science. 1995;268:1749-1753.
62. Lim DS, Kirsch DG, Canman CE, et al. ATM binds to betaadaptin in cytoplasmic vesicles. P roc Natl Acad Sci USA. 1998; 95:10146-10151.
63. Barlow C, Hirotsune S, Paylor R, et al. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell. 1996;86:159-171.
64. Mimaki T, Itoh N, Abe J, et al. Neurological manifestations in xeroderma pigmentosum. Ann Neural. 1986;20:70-75.
65. Otsuka F, Robbins JH. The Cockayne syndrome-an inherited multisystem disorder with cutaneous photosensitivity and defective repair of DNA: comparison with xeroderma pigmentosum. Am J Dermatopathol. 1985;7:387-392.
66. Ozdirim E, Topcu M, Ozon A, Cila A. Cockayne syndrome: review of 25 cases. Pediatr Neurol. 1996;15:312-316.
67. Nouspikel T, Lalle P, Leadon SA, Cooper PK, Clarkson SG. A common mutational pattern in Cockayne syndrome patients from xeroderma pigmentosum group G: implications for a second XPG function. Proc Natl Acad Sci U S A. 1997;94:3116-3121.
68. Stefanini M, Fawcett H, Botta E, Nardo T, Lehmann AR. Genetic analysis of twenty-two patients with Cockayne syndrome. Hum Genet. 1996;97:418-423.
69. Henning KA, Li L, lyer N, et al. The Cockayne syndrome group A gene encodes a WD repeat protein that interacts with CSB protein and a subunit of RNA polymerase II TFIIH. Cell. 1995; 82:555-564.
70. Wood RD. DNA repair: seven genes for three diseases. Nature. 1991 ;350:190.
71. Lutz R, Bodensteiner J, Schaefer B, Gay C. X-linked olivopontocerebellar atrophy. Clin Genet. 1989;35:417-422.
72. Spira PJ, McLeod JG, Evans WA. A spinocerebellar degeneration with X-linked inheritance. Brain. 1979; 102:27-41.
73. Wienker TF, von Reutern GM, Ropers HH. Progressive myoclonus epilepsy: a variant with probable X-linked inheritance. Hum Genet. 1979;49:83-89.
74. Bertini E, Cusmai R, de Saint Basile G, et al. Congénital X-linked ataxia, progressive myoclonic encephalopathy, macular degeneration and récurrent infections. Am J Med Genêt. 1992;43:443451.
75. Bindoff LA, Birch-Machin MA, Farnsworth L, Gardner-Medwin D, Lindsay JG, Turnbull DM. Familial intermittent ataxia due to a defect of the El component of pyruvate dehydrogenase complex. J Neurol Sci. 1989;93:311-318.
76. Pagon RA, Bird TD, Detter JC, Pierce I. Hereditary sideroblastic anaemia and ataxia: an X linked recessive disorder.,J Med Genet. 1985;22:267-273.
77. Raskind WH, Wijsman E, Pagon RA, et al. X-linked sideroblastic anemia and ataxia: linkage to phosphoglycerate kinase at Xql3. Am J Hum Genet. 1991;48:335-341.
78. Schmidley JW, Levinsohn MW, Manetto V. Infantile X-linked ataxia and deafness: a new clinicopathologic entity? Neurology. 1987;37:1344-1349.
79. Berman W, Haslam RH, Koningsmark BW, Capute AJ, Migeon CJ. A new familial syndrome with ataxia, hearing loss, and mental retardation: report of three brothers. Arch Neurol. 1973; 29:258-261.
80. Farlow MR, DeMyer W, Dlouhy SR, Hodes ME. X-linked recessive inheritance of ataxia and adult-onset dementia: clinical features and preliminary linkage analysis. Neurologv. 1987;37:602607.
81. Apak S, Yuksel M, Ozmen M, Saka N, Darendeliler F, Neuhauser G. Heterogeneity of X-linked recessive (spino)cerebellar ataxia with or without spastic diplegia. Am J Med Genet. 1989;34:155158.
82. Tranebjaerg L, Lou H, Andresen J. New X-linked syndrome with apraxia, ataxia, and mental deficiency: clinical, cytogenetic and neuropsychological studies in two Danish families. Am J Med Genet. 1992;43:498-504.
83. Arts WF, Loonen MC, Sengers RC, Slooff JL. X-linked ataxia, weakness, deafness, and loss of vision in early childhood with a fatal course. Ann Neural. 1993:33:535-539.
84. Konigsmark BW, Weiner LP. The olivopontocerebellar atrophies: a review. Medicine (Baltimore). 1970;49:227-241.
85. Harding AE. The clinical features and classification of the late onset autosomal dominant cerebellar ataxias: a study of 11 families, including descendants of 'the Drew family of Walworth.' Brain. 1982; 105:1-28.
86. Campanella G, Filla A, De Michèle G. Classifications of hereditary ataxias: a critical overview. Ada Neural (Napoli). 1992; 14: 408-419.
87. Koshy BT, Zoghbi HY. The CAGJpolyglutamine tract diseases: gene products and molecular pathogenesis. Brain Pathol. 1997;7: 927-942.
88. Bates GP, Mangiarini L, Mahal A, Davies SW. Transgenic models of Huntington's disease. Hum Mol Genet. 1997;6:1633-1637.
89. Sasaki H, Fukazawa T, Yanagihara T, et al. Clinical features and natural history of spinocerebellar ataxia type 1. Acta Neurol Scand. 1996;93:64-71.
90. Fukazawa T, Sasaki H, Kikuchi S, Hamada K, Hamada T, Tashiro K. Spinocerebellar ataxia type 1 and familial spontaneous pneumothorax. Neurology. 1997;49:1460-1462.
91. Mascalchi M, Tosetti M, Plasmati R, et al. Proton magnetic resonance spectroscopy in an Italian family with spinocerebellar ataxia type I. Ann Neurol. 1998;43:244-252.
92. Burk K, Abele M, Fetter M, et al. Autosomal dominant cerebellar ataxia type I clinical features and MRI in families with SCA1, SCA2 and SCA3. Brain. 1996:119:1497-1505.
93. Oilman S, Sima AA, Junck L, et al. Spinocerebellar ataxia type 1 with multiple system degeneration and glial cytoplasmic inclusions. Ann Neurol. 1996:39:241-255.
94. Orr HT, Chung MY, Banfi S, et al. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat Genet. 1993:4:221-226.
95. Zoghbi HY, Jodice C, Sandkuijl LA, et al. The gene for autosomal dominant spinocerebellar ataxia (SCA1) maps telomeric to the HLA complex and is closely linked to the D6S89 locus in three large kindreds. Am J Hum Genet. 1991:49:23-30.
96. Servadio A, Koshy B, Armstrong D, Antalffy B, Orr HT, Zoghbi HY. Expression analysis of the ataxin-1 protein in tissues from normal and spinocerebellar ataxia type 1 individuals. Nat Genet. 1995;10:94-98.
97. Chong SS, McCall AE, Cota J, et al. Gametic and somatic tissuespecific heterogeneity of the expanded SCA1 CAG repeat in spinocerebellar ataxia type I. Nat Genet. 1995; 10:344-350.
98. Chung MY, Ranum LP, Duvick LA, Servadio A, Zoghbi HY, Orr HT. Evidence for a mechanism predisposing to intergenerational CAG repeat instability in spinocerebellar ataxia type I. Nat Genet. 1993;5:254-258.
99. Burright EN, Davidson JD, Duvick LA, Koshy B, Zoghbi HY, Orr HT. Identification of a self-association region within the SCA1 gene product, ataxin-1. Hum Mol Genet. 1997:6:513-518.
100. Matilla A, Koshy BT, Cummings CJ, Isobe T, Orr HT, Zoghbi HY. The cerebellar leucine-rich acidic nuclear protein interacts with ataxin-1 [published correction appears in Nature. 1998; 391:818]. Nature. 1997;389:974-978.
101. Skinner PJ, Koshy BT, Cummings CJ, et al. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures [published correction appears in Nature. 1998:391:307]. Nature. 1997:389:971-974.
102. Koshy B, Matilla T, Burright EN, et al. Spinocerebellar ataxia type-1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde-3-phosphate dehydrogenase. Hum Mol Genet. 1996:5:1311-1318.
103. Cummings CJ, Mancini MA, Antalffy B, DeFranco DB, Orr HT, Zoghbi HY. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCAl. Nat Genet. 1998;19:148-154.
104. Orozco Diaz G, Nodarse Fleites A, Cordoves Sagaz R, Auburger G. Autosomal dominant cerebellar ataxia: clinical analysis of 263 patients from a homogeneous population in Holguin, Cuba. Neurology. 1990:40:1369-1375.
105. Gispert S, Twells R, Orozco G, et al. Chromosomal assignment of the second locus for autosomal dominant cerebellar ataxia (SCA2) to chromosome 12q23-24.1. Nat Genet. 1993;4:295-299.
106. Geschwind DH, Perlman S, Figueroa CP, Treiman LJ, Pulst SM. The prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia. Am J Hum Genet. 1997;60:842-850.
107. Zhou YX, Wang GX, Tang BS, et al. Spinocerebellar ataxia type 2 in China: molecular analysis and genotype-phenotype correlation in nine families. Neurology. 1998;51:595-598.
108. Giunti P, Sabbadini G, Sweeney MG, et al. The role of the SCA2 trinucleotide repeat expansion in 89 autosomal dominant cerebellar ataxia families: frequency, clinical and genetic correlates. Brain. 1998:121:459-467.
109. Burk K, Stevanin G, Didierjean O, et al. Clinical and genetic analysis of three German kindreds with autosomal dominant cerebellar ataxia type I linked to the SCA2 locus. J Neurol. 1997;244:256-26l.
110. Sasaki H, Fukazawa T, Wakisaka A, et al. Central phenotype and related varieties of spinocerebellar ataxia 2 (SCA2): a clinical and genetic study with a pedigree in the Japanese. J Neurol Sci. 1996:144:176-181.
111. Klockgether T, Skalej M, Wedekind D, et al. Autosomal dominant cerebellar ataxia type I: MRI-based volumetry of posterior fossa structures and basal ganglia in spinocerebellar ataxia types 1, 2 and 3. Brain. 1998:121:1687-1693.
112. Robitaille Y, Schut L, Kish SJ. Structural and immunocytochemical features of olivopontocerebellar atrophy caused by the spinocerebellar ataxia type 1 (SCA-1) mutation define a unique phenotype. Acta Neuropathol (Berl). 1995:90:572-581.
113. Schols L, Gispert S, Vorgerd M, et al. Spinocerebellar ataxia type 2: génotype and phenotype in German kindreds. Arch Neurol. 1997:54:1073-1080.
114. Pulst SM, Nechiporuk A, Nechiporuk T, et al. Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat Genet. 1996; 14:269-276.
115. Sanpei K, Takano H, Igarashi S, et al. Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nat Genet. 1996:14:277-284.
116. Cancel G, Durr A, Didierjean O, et al. Molecular and clinical correlations in spinocerebellar ataxia 2: a study of 32 families. Hum Mol Genet. 1997;6:709-715.
117. Higgins JJ, Nee LE, Vasconcelos O, et al. Mutations in American families with spinocerebellar ataxia (SCA) type 3: SCA3 is allelic to Machado-Joseph disease. Neurology. 1996;46:208-213.
118. Nakano KK, Dawson DM, Spence A. Machado disease: a hereditary ataxia in Portuguese emigrants to Massachusetts. Neurology. 1972:22:49-55.
119. Durr A, Stevanin G, Cancel G, et al. Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features. Ann Neurol. 1996:39:490-499.
120. Kaneko A, Narabayashi Y, Itokawa K, et al. A case of MachadoJoseph disease presenting with spastic paraparesis [letter]. J Neuroi Neurosurg Psychiatry. 1997;62:542-543.
121. van Schaik IN, Jobsis GJ, Vermeulen M, Keizers H, Bolhuis PA, de Visser M. Machado-Joseph disease presenting as severe asymmetric proximal neuropathy. J Neurol Neurosurg Psychiatry. 1997:63:534-536.
122. Takiyama Y, Sakoe K. Nakano I, Nishizawa M. Machado-Joseph disease: cerebellar ataxia and autonomie dysfunetion in a patient with the shortest known expanded allele (56 CAG repeat units) of the MJD1 gene. Neurology. 1997;49:604-606.
123. Sudarsky L. Coutinho P. Machado-Joseph disease. Clin Nenrosci. 1995:3:17-22.
124. Murata Y, Yamaguchi S, Kawakami H. et al. Characteristic magnetic resonance imaging findings in Machado-Joseph disease. Arch Neural. 1998:55:33-37.
125. Taniwaki T. Sakai T. Kobayashi T. et al. Positron emission tomography (PET) in Machado-Joseph disease. .J Neural Sci. 1997-I 45:63-67.
126. Soong BW. Liu RS. Positron emission tomography in asymptomatic gene carriers of Machado-Joseph disease. J Neural Nenrosurg Psychiatry. 1998:64:499-504.
127. Takiyama Y. Nishizawa M. Tanaka H. et al. The gene for Machado-Joseph disease maps to human chromosome 14q. Nat Genet. 1993:4:300-304.
128. Twist EC. Casaubon EK. Ruttledge MH. et al. Machado Joseph disease maps to the same region of chromosome 14 as the spinocerebellar ataxia type 3 locus. .J Med Genet. 1995:32:2531.
129. Stevanin G. Cancel G. Durr A. et al. The gene for spinal cerebellar ataxia 3 (SCA3) is located in a region of approximately 3 cM on chromosome 14q24.3-q32.2. Am ,J Hum Genet. 1995:56:193201.
130. Maruyama H, Nakamura S. Matsuyama Z. et al. Molecular features of the CAG repeats and clinical manifestation of MachadoJoseph disease. Hum Mal Genet. 1995:4:807-812.
131. Cancel G. Gourfinkel-An I. Stevanin G. et al. Somatic mosaicism of the CAG repeat expansion in spinocerebellar ataxia type 3J Machado-Joseph disease. Hum Mutât. 1998:11:23-27.
132. Takiyama Y. Shimazaki H. Morita M. et al. Maternal anticipation in Machado-Joseph disease (MJD): some maternal factors independent of the number of CAG repeat units may play a role in genetic anticipation in a Japanese MJD family. ,J Neural Sci. 1998:155:141-145.
133. Onodera O. Idezuka J. Igarashi S. et al. Progressive atrophy of cerebellum and brainstem as a function of age and the size of the expanded CAG repeats in the MJD1 gene in Machado-Joseph disease. Ann Neural. 1998:43:288-296.
134. Paulson HE. Das SS. Crino PB. et al. Machado-Joseph disease gene product is a cytoplasmic protein widely expressed in brain. Ann Neural. 1997:41:453-462.
135. Paulson HE. Perez MK. Trottier Y. et al. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron. 1997:19:333-344.
136. Biemond A. Ea forme radiculo-cordonnale postériure des dé générescences spino-ccrébelleuses. Rev Neural. 1954:91:221.
137. Nachmanoff DB. Segal RA. Dawson DM. Brown RB. De Girolami U. Hereditary ataxia with sensory neuronopathy: Biemond's ataxia. Neurology. 1997:48:273-275.
138. Flanigan K. Gardner K. Alderson K. et al. Autosomal dominant spinocerebellar ataxia with sensory axonal neuropathy (SCA4): clinical description and genetic localization to chromosome 16q22.1. Am J Hum Genet'. 1996:59:392-399.
139. Ranum EP. Schut EJ. Eundgren JK. Orr HT. Eivingston DM. Spinocerebellar ataxia type 5 in a family descended from the grandparents of President Eincoln maps to chromosome 11. Nat Genet. 1994:8:280-284.
140. Nee EE, Higgins JJ. Should spinocerebellar ataxia type 5 be called Eincoln ataxia? Neurology. 1997:49:298-302.
141. Koeppen AH. The hereditary ataxias. J Neuropathol Exp Neural. 1998:57:531-543.
142. Schols E, Kruger R. Amoiridis G. Przuntek H, Epplen JT, Riess O. Spinocerebellar ataxia type 6: genotype and phenotype in German kindreds..J N enrol Neiirosurg Psvcliiatry. 1998:64:6773.
143. Watanabe H. Tanaka F. Matsumoto M. et al. Frequency analysis of autosomal dominant cerebellar ataxias in Japanese patients and clinical characterization of spinocerebellar ataxia type 6. Clin Genet. 1998:53:13-19.
144. Matsumura R. Futamura N. Fujimoto Y. et ai. Spinocerebellar ataxia type 6: molecular and clinical features of 35 Japanese patients including one homozygous for the CAG repeat expansion. Neurology. 1997:49:1238-"l 243.
145. Geschwind DH. Perlman S. Figueroa KP. Karrini J. Baloh RW. Pulst SM. Spinocerebellar ataxia type 6: frequency of the mutation and genotype-phenotype correlations. Neurology. 1997: 49:1247-1251.
146. Ikeuchi T. Takano H. Koide R. et al. Spinocerebellar ataxia type 6: CAG repeat expansion in otlA voltage-dependent calcium channel gene and clinical variations in Japanese population. Ann Neurol. 1997:42:879-884.
147. Jen JC. Yue Q. Karrim J. Nelson SF. Baloh RW. Spinocerebellar ataxia type 6 with positional vertigo and acetazolamide responsive episodic ataxia. .J Neurol Neurosurg Ps\chiutr\. 1998:65: 565-568.
148. 1A-voltage-dependent calcium channel. Nat Genet. 1997:15:62-69.
149. Yabe I. Sasaki H. Matsuura T. et al. SCA6 mutation analysis in a large cohort of the Japanese patients with late-onset pure cerebellar ataxia..J Neurol Sci. 1998:156:89-95.
150. Forsgren L. Libelius R. Holmberg M. et al. Muscle morphology and mitochondrial investigations of a family with autosomal dominant cerebellar ataxia and retinal degeneration mapped to chromosome 3p 12-p21.1..J Neurol Sci. 1996:144:91 -98.
151. Gouw LG. Digre KB. Harris CP. Haines JH. Ptaeek LJ. Autosomal dominant cerebellar ataxia with retinal degeneration: clinical, neuropathologie, and genetic analysis of a large kindred. Neurology. 1994:44:1441-1447.
152. Jobsis GJ. Weber JW. Bartli PG. et al. Autosomal dominant cerebellar ataxia with retinal degeneration (ADCA II): clinical and neuropathological findings in two pedigrees and genetic linkage to 3p 12-p21.1..J Neurol Nenrosurg Psyeliiatrv. 1997;62: 367-371.
153. Holmberg M. Johansson J. Forsgren L. Heijbel J. Sandgren O. Holmgren G. Localization of autosomal dominant cerebellar ataxia associated with retinal degeneration and anticipation to chromosome 3pl2-p21.1. Hum Mol Genet. 1995:4:1441-1445.
154. Koob MD. Moseley ML. Schul LJ. et al. An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8). Nat Genet. 1999:21:379-384.
155. Krahe R. Ashizawa T. Abbruzzese C. et al. Effect of myotonic dystrophy trinucleotide repeat expansion on DMPK transcription and processing. Genonucs. 1995:28:1-14.
156. Grewal RP. Tayag E. Figueroa KP. et al. Clinical and genetic analysis of a distinct autosomal dominant spinocerebellar ataxia. Neurology. 1998:51:1423-1426.
157. Zu L. Figueroa KP. Grewal R. Pulst SM. Mapping of a new autosomal dominant spinocerebellar ataxia to chromosome 22. Am J Hum Genet. 1999:64:594-599.
158. Burke JR. Wingfield MS. Lewis KE. et al. The Haw River syndrome: dentatorubropallidoluysian atrophy (DRPLA) in an African-American family. Nat Genet. 1994:7:521-524.
159. Warner TT. Williams L. Harding AE. DRPLA in Europe [letter]. Nat Genet. 1994:6:225.
160. Becher MW. Rubinsztein DC. Leggo J. et al. Dentatorubral and pallidoluysian atrophy (DRPLA): clinical and neuropathological findings in genetically confirmed North American and European pedigrees. Mov Disonl. 1997:12:519-530.
161. Kurohara K, Kuroda Y, MaruyamaH, étal. Homozygosity for an allele carrying intermediate CAG repeats in the dentatorubralpallidoluysian atrophy (DRPLA) gene results in spastic paraplegia. Neurology. 1997;48:1087-1090.
162. Koide R, Onodera O, Ikeuchi T, et al. Atrophy of the cerebellum and brainstem in dentatorubral pallidoluysian atrophy: influence of CAG repeat size on MRI findings. Neurology. 1997;49:16051612.
163. Koide R, Ikeuchi T, Onodera O, et al. Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nat Genet. 1994;6:9-13.
164. Nagafuchi S, Yanagisawa H, Sato K, et al. Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p. Nat Genet. 1994;6:14-18.
165. Knight SP, Richardson MM, Osmand AP, Stakkestad A, Potter NT. Expression and distribution of the dentatorubral-pallidoluysian atrophy gene product (atrophin-1Jdrplap) in neuronal and non-neuronal tissues. J Neurol Sci. 1997; 146:19-26.
166. Hayashi Y, Kakita A, Yamada M, et al. Hereditary dentatorubralpallidoluysian atrophy: detection of widespread ubiquitinated neuronal and glial intranuclear inclusions in the brain. Acta Neuropathol (Berl). 1998;96:547-552.
167. Miyashita T, Nagao K, Ohmi K, Yanagisawa H, Okamura-Oho Y, Yamada M. Intracellular aggregate formation of dentatorubral-pallidoluysian atrophy (DRPLA) protein with the extended polyglutamine. Biochem Biophys Res Commun. 1998; 249:96-102.
168. Burke JR, Enghild JJ, Martin ME, et al. Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nat Med. 1996;2:347-350.
169. Griggs RC, Moxley RT III, Lafrance RA, McQuillen J. Hereditary paroxysmal ataxia: response to acetazolamide. Neurology. 1978;28:1259-1264.
170. Lubbers WJ, Brunt ER, Scheffer H, et al. Hereditary myokymia and paroxysmal ataxia linked to chromosome 12 is responsive to acetazolamide. J Neural Neurosurg Psychiatry. 1995;59:400405.
171. Brunt ER, van Weerden TW. Familial paroxysmal kinesigenic ataxia and continuous myokymia. Brain. 1990;! 13:1361-1382.
172. Baloh RW, Yue Q, Furman JM, Nelson SF. Familial episodic ataxia: clinical heterogeneity in four families linked to chromosome \9p.AnnNeurol. 1997;41:8-16.
173. Teh BT, Silburn P, Lindblad K, et al. Familial periodic cerebellar ataxia without myokymia maps to a 19-cM region on 19p 13. Am J HumGenet. 1995;56:1443-1449.
174. Browne DL, Gancher ST, Nutt JG, et al. Episodic ataxiaJ myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat Genet. 1994;8: 136-140.
175. Joutel A, Bousser MG, Biousse V, et al. A gene for familial hémiplégie migraine maps to chromosome 19. Nat Genet. 1993; 5:40-45.
176. Ophoff RA, Terwindt GM, Vergouwe MN, et al. Familial hémiplégie migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell. 1996;87: 543-552.
177. Jodice C, Mantuano E, Veneziano L, et al. Episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6) due to CAG repeat expansion in the CACNA1A gene on chromosome 19p. Hum Mol Genet. 1997;6:1973-1978.